Antibiotics are a class of medications used to prevent and treat infections caused by bacteria. They work either by killing bacteria outright (bactericidal action) or by inhibiting their growth and reproduction (bacteriostatic action), allowing the body’s immune system to clear the infection. Unlike antiviral, antifungal, or antiparasitic drugs, antibiotics are specifically targeted at bacteria and are ineffective against viral illnesses such as the common cold, influenza, or most cases of acute bronchitis.
The modern era of antibiotics began with the discovery of penicillin by Alexander Fleming in 1928, when he observed that a mold, later identified as Penicillium notatum, inhibited the growth of Staphylococcus bacteria on a culture plate. This observation led, through the work of Ernst Chain, Howard Florey, and others, to the isolation, mass production, and clinical use of penicillin in the early 1940s, revolutionizing the treatment of bacterial infections such as pneumonia, sepsis, and syphilis. Subsequent decades saw the development of many additional antibiotic classes, including sulfonamides, aminoglycosides, tetracyclines, macrolides, cephalosporins, fluoroquinolones, carbapenems, and others, each with distinct chemical structures, mechanisms of action, and spectra of activity.
Antibiotics act through several main mechanisms. Some, such as beta-lactams (including penicillins and cephalosporins), inhibit bacterial cell wall synthesis, causing the bacteria to weaken and lyse. Others, like aminoglycosides and macrolides, interfere with protein synthesis by binding to bacterial ribosomes. Fluoroquinolones disrupt DNA replication by targeting bacterial DNA gyrase and topoisomerase enzymes, while drugs such as sulfonamides and trimethoprim interfere with folic acid synthesis, a metabolic pathway essential for bacterial growth. Because these targets differ from human cellular processes, antibiotics can be selectively toxic to bacteria while relatively sparing human cells, though side effects and toxicity can still occur.
Clinically, antibiotics are chosen based on the likely causative organism, the site of infection, patient-specific factors (such as allergies, kidney and liver function, pregnancy status, and other medications), and local patterns of bacterial resistance. Some antibiotics are narrow-spectrum, targeting a limited range of bacteria, while others are broad-spectrum and active against many different species. In serious infections, clinicians may begin with a broad-spectrum agent while awaiting culture and sensitivity results, then narrow therapy once the specific pathogen and its susceptibilities are known. Appropriate dosing, route of administration (oral, intravenous, intramuscular, topical), and duration of therapy are critical to achieving cure while minimizing adverse effects.
Antibiotics can cause side effects ranging from mild to severe. Common adverse effects include gastrointestinal upset, diarrhea, and, in some cases, disruption of the normal microbiota leading to overgrowth of organisms such as Clostridioides difficile or yeast. Allergic reactions, including rash, hives, and anaphylaxis, may occur with certain agents, particularly penicillins and related beta-lactams. Some antibiotics have specific toxicities—for example, aminoglycosides can cause kidney damageDraft overviewDamageIn Jain philosophical literature, the concept of **damage** is not treated merely as physical harm but as a multi‑layered phenomenon involving ethical, karmic, and ontological dimensions. Damage (often expressed through … and hearing loss, and fluoroquinolones have been associated with tendon injury and effects on the nervous system. Because of these risks, antibiotics should be used only when there is clear evidence or strong suspicion of bacterial infection.
A major global concern is antibiotic resistance, the ability of bacteria to survive and grow despite exposure to drugs that would previously have killed them or inhibited their growth. Resistance arises through genetic mutations and the acquisition of resistance genes via horizontal transfer between bacteria. Mechanisms include producing enzymes that inactivate the drug (such as beta-lactamases), altering drug targets, reducing drug uptake, and increasing efflux of the antibiotic from the bacterial cell. Misuse and overuse of antibiotics—such as prescribing them for viral infections, using them without medical supervision, or not completing prescribed courses—accelerate the emergence and spread of resistant strains. Multidrug-resistant organisms complicate treatment, increase healthcare costs, and contribute to morbidity and mortality worldwide.
Modern strategies to combat antibiotic resistance include antimicrobial stewardship programs that promote judicious use of antibiotics, infection prevention and control measures in healthcare settings, surveillanceDraft overviewSurveillanceIn Jain studies, “surveillance” is not a classical doctrinal term, but the concept aligns closely with the tradition’s sustained attention to *internal monitoring*, *ethical vigilance*, and *cosmic observation* through k… of resistance patterns, and ongoing research into new antibiotics and alternative therapies. These alternatives may involve bacteriophage therapy, immunotherapies, anti-virulence agents that disarm bacteria without killing them, and improved diagnostics that rapidly identify pathogens and resistance profiles. Despite the challenges, antibiotics remain indispensable tools in medicineDraft overviewMedicineIn Jain traditions, “medicine” (auṣadha) is understood through a layered framework that integrates non‑violence (ahiṃsā), karmic theory, monastic discipline, and lay responsibility. Jain texts do not reject medical care;…, enabling routine surgeries, cancer chemotherapy, organ transplantation, and intensive care treatments that would be far more dangerous without effective control of bacterial infections.